Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhiying Xu
Observed name:
Z. Xu
Institutions:
Obstetrics and Gynecology Hospital of Fudan University,
Henan Medical University
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Wuhan Business University,
Obstetrics and Gynecology Hospital of Fudan University,
Henan Medical University
ORCID:
0000-0001-7114-6814
Observed ORCID:
0000-0001-7114-6814
OpenAlex ID:
A5102720909
Proteogenomic insights into early-onset endometrioid endometrial carcinoma: predictors for fertility-sparing therapy response
2024
·
Zhe Hu
, Zimeng Wu
, et al.
·
Nature Genetics
·
33
PDF
Characteristics of progestin-insensitive early stage endometrial cancer and atypical hyperplasia patients receiving second-line fertility-sparing treatment
2021
·
Shuang Zhou
, Zhiying Xu
, et al.
·
Journal of Gynecologic Oncology
·
31
Outcomes of fertility preservation treatments in patients with endometrial cancer with different molecular classifications based on an NGS panel
2023
·
Yan Xu
, Mingming Zhao
, et al.
·
Frontiers in Oncology
·
23
Fertility-sparing treatment outcomes using immune checkpoint inhibitors in endometrial cancer patients with Lynch syndrome
2025
·
Xintong Yang
, Yu Xue
, et al.
·
Journal of Gynecologic Oncology
·
16
PDF
Comparison of the effect of oral megestrol acetate with or without levonorgestrel-intrauterine system on fertility-preserving treatment in patients with early-stage endometrial cancer: a prospective, open-label, randomized controlled phase II trial (ClinicalTrials.gov NCT03241914)
2022
·
Zhiying Xu
, Bingyi Yang
, et al.
·
Journal of Gynecologic Oncology
·
13
NrCAM secreted by endometrial stromal cells enhances the progestin sensitivity of endometrial cancer cells through epigenetic modulation of PRB
2022
·
Yali Cheng
, Liying Xie
, et al.
·
Cancer Gene Therapy
·
10
PDF
Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: A prospective, open-label, randomized controlled phase II study
2023
·
Zhiying Xu
, Bingyi Yang
, et al.
·
Gynecologic Oncology
·
9
PDF
Menopausal Status Combined with Serum CA125 Level Significantly Predicted Concurrent Endometrial Cancer in Women Diagnosed with Atypical Endometrial Hyperplasia before Surgery †
2021
·
Yaochen Lou
, Jiongbo Liao
, et al.
·
Diagnostics
·
9
PDF
OP009/#222 Combined oral megestrol acetate/levonorgestrel-intrauterine system for atypical endometrial hyperplasia: a single-center prospective randomized controlled pilot study
2021
·
Z. Xu
, B. Yang
, et al.
·
International Journal of Gynecological Cancer
·
2
PDF
GNB2 promotes breast cancer progression by up-regulating HSPA5/GPX4 and inhibiting ferroptosis
2025
·
Yongxia Wang
, Rong Liu
, et al.
·
Molecular and Cellular Biochemistry
·
1
Farmers Assistance Program Based on Artificial Intelligence (AI) and Big Data
2024
·
Qi Gao
, Liling Zhang
, et al.
·
International Journal of Computer Science and Information Technology
·
1
PDF
Suspected myometrial invasion on MRI is correlated with worse outcomes of fertility-preserving treatment in young women with endometrial cancer
2024
·
Chengcheng Ning
, Zhiying Xu
, et al.
·
Holistic Integrative Oncology
·
1
2022-RA-170-ESGO Comparison of the effect of levonorgestrel-intrauterine system with or without oral megestrol acetate on fertility-preserving treatment in patients with atypical endometrial hyperplasia: a prospective, open-label, randomized controlled phaseIIstudy
2022
·
Zhiying Xu
, Bingyi Yang
, et al.
·
International Journal of Gynecological Cancer
·
1
PDF
Transcriptome and metabolome changes uncover the potential mechanism of high-fat diet induced obesity under hypoxia condition
2024
·
Mingming Fan
, Qingqing Chen
, et al.
·
Research Square
Show more works
View as search
Works count:
14
Citation count:
150
H-index:
8
I10-index:
6
Year
Topic
Type